Nektar Therapeutics (NASDAQ:NKTR)

2.61
Delayed Data
As of Jan 27
 +0.145 / +5.89%
Today’s Change
1.99
Today|||52-Week Range
11.59
+15.27%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Zalevsky Jonathan
Chief Research & Development Officer
Sale8/18/202273,716$4.65$342.8K-44.23%
Robin Howard W
President & Chief Executive Officer
Sale5/16/202236,529$3.95$144.3K-32.73%
Robin Howard W
President & Chief Executive Officer
Sale2/16/202212,480$10.95$136.7K-76.68%
Robin Howard W
President & Chief Executive Officer
Sale11/16/202238,014$3.57$135.7K-25.85%
Zalevsky Jonathan
Chief Research & Development Officer
Sale2/16/202210,912$10.95$119.5K-76.68%
Zalevsky Jonathan
Chief Research & Development Officer
Sale5/16/202221,673$3.95$85.6K-32.73%
Labrucherie Gilbert M
Chief Operating & Financial Officer & Senior VP
Sale2/16/20227,579$10.95$83.0K-76.68%
Eastham Karin
Director
Sale9/13/202221,267$3.61$76.8K-26.48%
Labrucherie Gilbert M
Chief Operating & Financial Officer & Senior VP
Sale5/16/202217,448$3.95$68.9K-32.73%
Robin Howard W
President & Chief Executive Officer
Sale8/16/202213,759$4.76$65.5K-44.23%
Page of 4